Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
Halperin
S A
SA
Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
Barreto
L
L
Eastwood
B J
BJ
Law
B
B
Roberts
E A
EA
D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000009:adverse effects / Q000276:immunology; D001886:Bordetella pertussis / Q000276:immunology*; D005260:Female; D010861:Fimbriae, Bacterial / Q000276:immunology; D006388:Hemagglutinins / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007223:Infant; D008297:Male; D010567:Pertussis Vaccine / Q000009:adverse effects / Q000276:immunology*; D014121:Toxoids / Q000009:adverse effects / Q000276:immunology; D018074:Vaccines, Conjugate / Q000009:adverse effects / Q000276:immunology
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D006388:Hemagglutinins; D010567:Pertussis Vaccine; D014121:Toxoids; D018074:Vaccines, Conjugate; C051093:pertussis toxoid